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Abstract
Background: Shock may complicate several acute childhood illnesses in hospitals within low-income countries and
has a high case fatality. Hypovolemic shock secondary to diarrhoea/dehydration and septic shock are thought to be
common, but there are few reliable data on prevalence or treatment that differ for the two major forms of shock.
Examining prevalence and treatment practices has become important since reports suggest high risks from liberal
use of fluid boluses in African children. The present study aims to estimate the prevalence, fluid management
practices and outcomes of shock among hospitalised children.
Methods: We analysed paediatric in-patient data collected using discharge case record review between October
2013 and February 2016 from 14 hospitals in Kenya which are part of a network (referred to as the Clinical
Information Network) using similar tools for standardised clinical records with care directed by the local clinical
team leaders. Data are from a period after dissemination of national guidance seeking to limit use of bolus fluids.
Results: A total of 74,402 children were admitted between October 2013 and February 2016. Children aged <
30 days or > 5 years, with severe acute malnutrition, surgical/burns, or cases with pre-defined minimum data sets
were excluded from analysis. This resulted in 42,937 patients meeting the inclusion criteria. Prevalence of clinically
diagnosed shock was 1.5 % (n = 622) and overall bolus use was 0.9 % (n = 366); 41 % (256/622) of children with
clinically diagnosed shock did not receive a fluid bolus (but had a fluid plan for management of dehydration).
Identified cases appeared mostly to be hypovolaemic shock secondary to dehydration/diarrhoea (94 %, 582/622),
with a high case fatality (34 %, 211/622). Overall mortality for all admitted children was 5 % (2115/42,937) and was
7.9 % (798/10,096) in children with dehydration/diarrhoea. The diagnosis of hypovolaemic shock was nearly always
accompanied by additional clinical diagnosis (99 %), most often pneumonia or malaria. Where bolus fluids were
used, they were prescribed in accordance with guidelines (isotonic fluid at correct volume) in 92 % of cases.
Inappropriate use of bolus fluids to treat milder forms of impaired circulation appeared very rarely.
Conclusion: A diagnosis of shock is uncommon at admission and use of fluid bolus is rare in admissions to
Kenyan hospitals. A fluid bolus, when prescribed, is mostly used in children with hypovolemic shock secondary
to dehydration and case fatality in these cases is high. We found little evidence of liberal use of fluid bolus that
might cause harm in a period following dissemination of national guidelines suggesting very strict criteria for fluid
bolus use.
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Background
Shock, defined as relative or absolute reduction of circu-
latory volume with consequent impaired tissue perfu-
sion, oxygen delivery and waste removal, has a high risk
of mortality and requires prompt appropriate interven-
tion [1, 2]. However, there is no consistent clinical
definition of shock and it may have a number of under-
lying causes, including cardiac, sepsis, hypovolaemia and
anaphylaxis [3–7]. Sepsis is thought to be the most com-
mon cause of shock in high-income countries, but hypo-
volaemia secondary to diarrhoea/dehydration is thought
to be predominant in low-income countries (LICs). The
World Health Organization (WHO) does not formally
recognise shock in its diarrhoea/dehydration case man-
agement guidelines [8], but this is provided for in its
Emergency Triage, Assessment and Treatment (ETAT)
guidelines [9]. However, the prevalence of shock (hypo-
volemic or septic) is poorly described in LICs [10, 11]. In
the FEAST trial, a large trial of fluid bolus resuscitation,
up to 57 % of acutely ill, febrile admitted children had
features associated with impaired perfusion, but only
2 % of participants enrolled met ETAT criteria for shock
[12]. The FEAST trial and the debate that followed its
publication showed that there’s little understanding on
how commonly clinicians diagnose shock in routine set-
tings, what they associate the diagnosis with, and how
often they initiate treatment for shock with fluid bolus.
The latter is of particular significance as bolus fluids
were shown to be harmful in the FEAST trial when used
in children without diarrhoea/dehydration [7, 13]. A lib-
eral approach to use of fluid bolus might therefore be
causing considerable harm in hospitalised children in
LICs where intensive care cannot be provided. This ana-
lysis aims to address these gaps in understanding by ex-
ploring the prevalence of shock, its clinically determined
aetiology, fluid management practices and outcomes
among hospitalised children aged under 5 years. It will
also help to estimate the magnitude of potential harm if
shock is treated with fluid boluses in non-diarrhoeal
cases. The study uses routine data collected from a net-
work of 14 hospitals in Kenya referred to as the Clinical
Information Network (CIN).
Methods
Study setting and data collection
Data for analysis was routinely obtained from the 14
hospitals in Kenya that form the CIN, which is a collab-
orative effort between the Kenya Medical Research
Institute (KEMRI), the Kenya Paediatric Association,
and Kenya’s Ministry of Health that aims to improve the
availability of data for decision making and to help im-
prove quality of care. A detailed description of the CIN
hospitals, their selection process, management and geo-
graphical spread has been previously provided [14]. In
summary, key partners at each site consist of the hos-
pital paediatrician, the nurse in charge of the paediatric
unit and the senior health records officer. A minimum
dataset, which consists of information required for na-
tional reporting of basic demographic features, diagnoses
and outcomes only, is collected for each admission in all
hospitals. A more comprehensive set of information on
disease care processes, which includes investigations and
treatment, is collected on all patients in 11 hospitals
with low-to-moderate workload and on a random subset
in three high workload hospitals. Minimum datasets are
also collected when the data clerk is on leave, for surgi-
cal/burns cases (because they are primarily admitted
outside paediatric areas), and on neonates admitted to
the paediatric wards. Minimum data sets do not have
detailed treatment information and were therefore ex-
cluded. Partnership is maintained through 4-monthly
meetings, 2-monthly written reports to hospitals and
phone calls by the network coordinator to the hospitals.
The hospitals use a standardised paediatrics admission
record and discharge forms and have one additional re-
cords clerk to collect data from medical records and la-
boratory reports. A sample of the paediatrics admission
record form can be found at the iDOC Africa website
[15]. Data is extracted from these forms as soon as a pa-
tient is discharged and entered into a non-proprietary
electronic tool, REDCap® [16], in line with detailed
standard operating procedures. Data on clinical presen-
tation, assessment, care processes for common condi-
tions, investigations and treatment given within the first
48 hours are collected together with discharge diagnoses
and outcomes. The database tool has been configured to
run error checks so corrections can be made on site be-
fore the data are uploaded and synchronised into a cen-
tral server. Further quality checks are done once the
data are synchronised and the clerks alerted to reconcile
any discrepancies noted. Data quality assurance, where
the study team randomly selects a sample of files that
have been entered by the clerks and re-enters the same
data, is done periodically to ascertain the accuracy of
data from the hospitals and as a form of supervision.
WHO syndromic criteria [8] are used to assign diagno-
ses for common clinical conditions by clinicians, in line
with national guidelines, with ICD-10 also entered for
each case. WHO syndromic definitions are used as
diagnostic categories in this paper. A detailed descrip-
tion of data collection is provided elsewhere [17]. Data
collection was commenced between October 2013 and
February 2014 in the 14 hospitals.
Data analysis
Data collection from the initiation of the network up to
February 2016 were analysed. Children with severe acute
malnutrition, aged < 30 days, with surgical/burns, those
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with minimal data sets, and those aged > 5 years were
excluded. Severe malnutrition cases were excluded as
they have distinct management fluid guidelines. Neo-
nates (<30 days old) were excluded because there is lack
of consensus on fluid management guidance with no
clear policy in Kenya, while children > 5 years old are
not covered by the Kenyan guidance that is the main
focus of the CIN. Otherwise, all cases with comprehen-
sive data not meeting exclusion criteria were included in
the analyses. To examine the prevalence of shock
amongst admissions, shock was defined as a child with
any of the following: a clinician’s indication that the
child had shock as a problem accompanying diarrhoea
and dehydration (an indication of the severity of fluid
loss); a diagnosis of shock associated with an underlying
cause (e.g. septic shock); or use of rapid bolus fluid
therapy in a child irrespective of diagnosis. When
attributing a probable cause for an admission with shock
(as defined above) we considered it to be hypovolaemic
(hypovolaemic shock) in nature in children with a
diagnosis of diarrhoea and dehydration and non-
hypovolaemic (other) in the absence of this diagnosis.
We examined the fluids prescribed for the treatment of
shock and calculated the volume per kilogram body
weight based on the fluid therapy plan and the recorded
admission weight. We also examined the recording of
key clinical features used in guidelines to support the
diagnosis of shock. Children fulfilled locally adapted
WHO criteria for shock (documented in national clinical
policy since 2013) if they had all four of the following:
impaired consciousness (AVPU score < V), weak/absent
pulse, cold hands and temperature gradient, and capil-
lary refill > 3 seconds, plus sunken eyes and slow skin
pinch. The presence of shock plus diarrhoea symptoms
classified such cases as diarrhoea-related hypovolaemic
shock. Impaired circulation was defined as presence of
any one of weak/absent pulse, cold hands and temperature
gradient, or capillary refill > 3 seconds. Information on
prevalence is summarised as proportions with shock or
impaired circulation among those admitted. Fluid treat-
ment of shock, number of boluses, types of shock noted,
and case fatality are summarised as frequencies and
proportions. Children with diarrhoea/dehydration and
shock were defined to have comorbidity if there was an-
other clinical diagnosis in addition to diarrhoea/dehydra-
tion. No imputation for missing data was done and
because this affects denominators, all numerators and de-
nominators are reported.
Results
Prevalence of shock, patient characteristics, and use of
fluid bolus
A total 74,402 children were admitted between October
2013 to February 2016 and 42,937 records (range 1154
to 5924 per hospital) were analysed after applying the
exclusion criteria above. Characteristics for the 42,937
participants are summarised in Table 1. Shock (as de-
fined in the Methods section) was an uncommon diag-
nosis and was only present in 1.45 % (622) of admitted
children (range 0.2–3.2 % per hospital); in 1.4 % (582/
622) of all admissions, the shock appeared to result from
hypovolaemia secondary to diarrhoea/dehydration, while
in 0.1 % of all admissions (40/622) shock was identified
in non-diarrhoeal cases (other shock). Sixty percent (24/
40) of those with other shock had fever and septic shock
was a possibility. Therefore, hypovolaemic shock com-
prised 94 % (582/622) of all cases of shock diagnosed. A
summary of shock diagnosis and fluid bolus use is
presented in Fig. 1. WHO criteria for shock were ful-
filled in only 0.1 % (41/42,937) of children. When in-
dividual clinical signs were considered, 7.5 % (3219/
42,937) of children in the study population met cri-
teria for impaired circulation; of these, 11 % (366/
3219) of children with impaired circulation received
rapid fluid bolus. Forty three percent (265/622) of pa-
tients with shock were female, 33 % (204/622) had
malaria, 1.4 % (9/622) had HIV, 46 % (286/622) had
pneumonia, 1.1 % (7/622) had tuberculosis, 13 % (81/
622) had meningitis, 1.1 % (7/622) had asthma, and
2.9 % (18/622) had rickets (Table 2).
Fluid bolus was prescribed in only 0.85 % (366/42,937) of
all admissions. Most boluses (89 %, 326/366) were given for
hypovolaemic shock and only 11 % (40/366) were given for
non-diarrhoeal shock (other shock). Forty four percent
(256/582) of children with diarrhoea/dehydration identified
as having shock (hypovolaemia) did not receive rapid fluid
bolus but received recommended fluid management of de-
hydration (WHO plan C). All the children with shock who
did not receive a rapid fluid bolus (but other recommended
fluid management) had hypovolaemia.
When a fluid bolus was prescribed, it was defined as
correctly prescribed if an isotonic fluid (normal saline or
Ringer’s lactate/Hartmann’s solution) was used at a vol-
ume of 20 mL/kg (±4 mL/kg) and was correct in 92 % of
cases. In a small number of cases (n = 30, 8 %), fluids
such as Half Strength Darrow’s/5 % Dextrose mix,
Ringer’s/5 % Dextrose mix, or 5 % Dextrose were used
for fluid boluses. One bolus was infused in 88 % of re-
cipients, 10 % received two boluses (all except one were
in children with diarrhoea/dehydration), and only one
patient each received 3 and 4 boluses (these children did
not have diarrhoea; one had severe anaemia/suspected
sepsis and the other had suspected sepsis).
Mortality and comorbidities
Five percent of all admission (n = 2115/42,937) died and
10 % (211/2115) of these deaths were associated with clin-
ically diagnosed shock. Mortality in children identified
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Table 1 Description of characteristics of eligible population
Overall characteristics
Demographic characteristics n (%)
Female sex, n (%)a 18,753 (43.7)
Anthropometric measures Mean (± SD)
Age in months 15.0 (11.7)
Weight, kg 8.7 (2.8)
Weight–height Z score –1.3 (1.2)
MUACb, cm 13.5 (1.6)
Height/length, cm 74.3 (11.4)
Illness features Mean (± SD)
Length of illness, days 4.3 (4.7)
Oxygen saturation 94.9 (6.2)
Heart rate/minute 124.2 (27.9)
Respiratory rate/minute 41.8 (13.4)
Axillary temperature (°C) 37.7 (1.2)
Airway and breathing Characteristic present, n (%) Characteristics absent, n (%) Missing, n (%)
Stridor 783 (1.8) 34,300 (79.9) 7854 (18.3)
Grunting 4165 (9.7) 32,192 (75.0) 6580 (15.3)
Crackles 8425 (19.6) 29,004 (67.6) 5508 (12.8)
Indrawing 11,383 (26.5) 25,697 (59.8) 5857 (13.6)
Tachypnoeac 13,236 (30.8) 18,240 (42.5) 11,461 (26.7)
Acidotic breathing 1019 (2.4) 34,935 (81.4) 6983 (16.3)
Central cyanosis 253 (0.6) 38,266 (89.1) 4418 (10.3)
Circulation
Tachycardiad 10,278 (23.9) 14,643 (34.1) 18,016 (42.0)
Sunken eyes 4749 (11.1) 29,158 (67.9) 9030 (21.0)
Delayed skin pinch 6702 (15.6) 28,077 (65.4) 8158 (19.0)
Capillary refill > 2 seconds 1620 (3.8) 27,352 (63.7) 13,965 (32.5)
Capillary refill > 3 seconds 312 (0.7) 28,660 (66.7) 13,965 (32.5)
Temperature gradiente 1432 (3.3) 27,313 (63.6) 14,192 (33.1)
Weak pulse volume 1766 (4.1) 32,951 (76.7) 8220 (19.1)
Pallor 5962 (13.9) 32,403 (75.5) 4572 (10.6)
Disability
Convulsions 9228 (21.5) 28,613 (66.6) 5096 (11.9)
Can drink/breastfeed? 29,586 (68.9) 5757 (13.4) 7594 (17.7)
Stiff neck 871 (2.0) 36,645 (85.3) 5421 (12.6)
Bulging fontanelle 453 (1.1) 34,861 (81.2) 7623 (17.8)
Impaired consciousnessf 2464 (5.7) 35,485 (82.6) 4988 (11.6)
Diagnoses
Anaemia 3774 (8.8) 39,163 (91.2) Nil
Asthma 1262 (2.9) 41,675 (97.1) Nil
Dehydration 7021 (16.4) 35,916 (83.6) Nil
HIV 401 (0.9) 355 (0.8) 42,181 (98.2)
Malaria 17,254 (40.2) 25,683 (59.8) Nil
Meningitis 5393 (12.6) 37,544 (87.4) Nil
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with shock was 34 % (211/622), and mortality was 31 %
(115/366) in the rapid bolus subgroup and 37.5 % (96/
256) in the no bolus subgroup (odds ratio (OR) = 0.76;
95 % confidence interval (CI), 0.55–1.07; P = 0.12).
Among children with hypovolaemic shock, mortality
in children who received rapid fluid bolus was 32.5 %
(106/326) compared to 37.5 % (96/256) in those who
only received WHO plan C (OR = 0.80; 95 % CI,
0.57–1.13; P = 0.21).
Most children with hypovolaemic shock had a second
diagnosis (referred to as comorbidity) and this was seen in
99 % (579/582) of cases. Additional diagnoses in patients
with shock are outlined in Table 2. Patients with hypovol-
aemic shock and a comorbid condition had an increased
risk of death when compared to those with diarrhoea only
(109/300 (36 %) vs. 35/147 (24 %), respectively; OR = 1.9;
95 % CI, 1.2–2.9; P = 0.008). Mortality in those with hypo-
volaemia plus malaria was 29 % (54/186) and in those with
hypovolemia plus pneumonia it was 42 % (111/267).
Discussion
We analysed data from CIN hospitals for prevalence of
shock and use of bolus fluids in order to give an estima-
tion of the prevalence of shock at admission and the use
of rapid fluid bolus. The study was undertaken in the
period immediately after dissemination of national
guidelines suggesting rapid bolus fluids should only be
used in children with four clinical features indicating
Table 1 Description of characteristics of eligible population (Continued)
Pneumonia 20,038 (46.7) 22,899 (53.3) Nil
Ricketts 962 (2.2) 41,975 (97.8) Nil
Tuberculosis 545 (1.3) 42,392 (98.7) Nil
Outcome
Death 2115 (4.9 %) n/a Nil
Table describes characteristics of all 42,937 patients who were eligible for analysis; means presented rather than median because data were not skewed
a489 (1.1 %) patients missed information on sex
bMid-upper arm circumference
cDefined as > 50 breaths/minute if aged ≤ 1 year and > 40 breaths/minute if aged > 1 year
dDefined as > 140 beats/minute if aged ≤ 1 year and > 120 beats/minute if aged > 1 year
eTemperature gradient
fAVPU score < A
Fig. 1 Flow diagram showing patients with shock and bolus administration. * 41 (0.1%) children met WHO criteria for shock and 7.5% (3,219/42,937)
had impaired circulation; 11% (366/3,219) of children with impaired circulation received fluid bolus
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shock who also had a history of diarrhoea and two signs
of dehydration (sunken eyes and prolonged skin pinch).
The data suggest shock is uncommonly diagnosed at ad-
mission in children aged 1 month to 59 months and that
most cases are diagnosed in the context of multiple signs
of hypovolaemia secondary to diarrhoea/dehydration.
Thus, while just under 1.5 % of admissions were diag-
nosed with shock, approximately 7.5 % of admissions
were noted to have at least one of the four clinical signs
associated with impaired perfusion. Use of fluid bolus is
rare (<1 % admissions) and is mostly used in those chil-
dren with clinically identified hypovolaemia and dehy-
dration (most with hypovolaemic shock).
Although shock is identified rarely, it has a high case
fatality and 10 % of all deaths were associated with the
clinical syndrome. Nearly all cases of shock secondary to
diarrhoea/dehydration also had a second diagnosis
(comorbidities) and having an additional diagnosis was
associated with an increased risk of death. Clinicians
mostly prescribed the guidance recommended bolus type
and volumes [18] and in 9/10 cases only a single bolus is
given although many children with diarrhoea/dehydra-
tion will then go on to continue with intravenous fluids
as part of ongoing management. The use of correctly
calculated fluid boluses may be attributed to long term
efforts to provide training in emergency care in Kenya
using the ETAT+ course and linked efforts to dissemin-
ate evidence-based national guidelines that provide this
information [19, 20]. However, there remains uncertainty
about the benefits of rapid bolus fluids even in children
with all four clinical signs of shock, a history of
diarrhoea and signs of dehydration. With a fatality rate
of over 30 % in this group, further studies of the benefits
and risks of aggressive fluid intervention may be
warranted.
These data from 14 Kenyan hospitals suggest that cli-
nicians rarely use fluid bolus to treat non-hypovolaemic
shock and extremely rarely use such boluses in those
with signs of impaired circulation only. As the FEAST
trial showed increased risk of mortality in children with
shock (defined more broadly than in this study) from
non-diarrhoeal cases and those who only have impaired
circulation, these data are therefore reassuring and per-
haps allay fears that considerable harm is being done
through widespread use of bolus fluids [12]. These data
do, however, represent a period in Kenya immediately
after a change in national guidelines, disseminated in
October 2013, recommending against use of fast-bolus
infusions in the absence of diarrhoea/dehydration. Such
Kenyan guidance was based on systematic review [21]
and a structured national guideline panel process [22].
Kenyan guidance predated the advice of WHO that also
now recommends against fast fluid bolus in the absence
of diarrhoea/dehydration in its ETAT guidance released
in 2016 [3, 9]. This new WHO guidance recommends
(based on expert opinion) early consideration of ino-
tropes, antibiotics and other treatments in the septic
shock management algorithm for cases that fail to re-
spond to initial, more cautious fluid bolus. This contin-
ued recommendation for some form of fluid bolus
remains contentious. Our finding that most children
even with hypovolaemic shock associated with diar-
rhoea/dehydration also have a secondary diagnosis of in-
fection (predominantly malaria and pneumonia) for
which rapid fluid boluses are thought to be harmful
brings into question how frontline clinicians, without ex-
pert training in critical care and with little access to
diagnostics, are expected to apply divergent guidelines
to manage a single patient.
There have been concerns that there is a high preva-
lence of severe sepsis in LICs with higher case fatality
than in high-income countries [10, 11]. High prevalence
of sepsis in LICs might be expected to correspond with
a common diagnosis of shock associated with febrile ill-
ness but not associated diarrhoea/dehydration. Our data
suggest clinicians are not often making a diagnosis at ad-
mission of probable septic shock (non-diarrhoeal shock),
suggesting that fulminant septic shock may still be rare
















Malariaa 106 (33) 80 (31) 18 (45) 204 (33)
Pneumoniaa 135 (41) 132 (52) 19 (48) 285 (46)
HIV positive or exposeda 5 (1.5) 4 (1.5) 0 9 (1.4)
Tuberculosisa 2 (0.6) 4 (1.6) 1 (2.5) 7 (1.1)
Meningitisa 26 (8) 50 (20) 5 (13) 81 (13)
Asthmaa 2 (0.6) 5 (2) 0 7 (1.1)
Ricketsa 5 (1.5) 13 (5) 0 18 (2.9)
aCondition is the presenting comorbidity in cases of hypovolaemic shock
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in Kenya. However, the diagnoses we report are almost
exclusively made on the basis of clinical signs inter-
preted often by clinicians with limited experience. Typic-
ally, measures of blood pressure and oxygen saturation
are not available and neither are microbiological investi-
gations of those for inflammatory markers [23]. Further-
more, although we had access to discharge diagnoses, it
is possible that shock emerged during the admission but
these diagnoses were not recorded. Our estimates of
prevalence of non-hypovolaemic shock may therefore be
low. In addition, the clinical identification of shock and
impaired circulation in Kenyan guidelines does not in-
clude children with severe tachycardia, a criterion used
in the FEAST study. Our study also included children
with diarrhoea/dehydration, many of whom were ex-
cluded from the FEAS study. Such differences in defini-
tions make direct comparison with the prevalence of
impaired circulation and of mortality between the two
reports difficult. However, we believe CIN hospitals are
fairly representative of practice in Kenyan hospitals in
LICs providing first referral level care, although the fact
that they receive regular feedback on their patterns of
mortality and morbidity and are engaged in a network
aiming to improve their documentation of illness over
time [14] may result in better adherence to recently dis-
seminated national guidelines for fluid management in
keeping with previous efforts to use multifaceted inter-
ventions, including feedback, to improve adherence to
guidelines in Kenya [24–26].
These findings need to be interpreted with consider-
ation for known limitations pertinent in registry research
such as ascertainment, selection and analytical biases
[27]. However, we suggest selection bias was unlikely be-
cause we analysed all eligible children across all 14 hos-
pitals. Ascertainment bias was reduced by using WHO
standardised case definitions, standard data collection
approaches and employing frequent data quality assur-
ance. However, results are based on what is recorded
about the care provided and it is possible that bolus
fluids were used but not recorded or that they were
prescribed but not given.
Improved use of simple bedside physiological mea-
sures together with biomarkers might improve the diag-
nosis of shock, help subclassify the clinical presentation
by cause and assist in management including targeted
anti-microbial or inotropic use. While fewer than 10 %
of the deaths amongst the cohort studied could be dir-
ectly associated with a diagnosis of shock on admission,
in these cases, case fatality was very high and some cases
may go unidentified. Comorbidity further increases the
risk of mortality in hypovolaemic shock. This constella-
tion of results suggests that the saving of lives associated
with shock will likely require detection and intervention
earlier in the disease course, more rapid referral where
needed and improved supportive care. It is also possible
that different treatment approaches are needed in chil-
dren with different patterns of comorbidity. For ex-
ample, less aggressive fluid regimens might perhaps be
tested, particularly in children with hypovolaemic shock
and signs of pneumonia. Such research will require large
scale collaborative efforts that could benefit from initia-
tives such as the clinical information network in Kenya.
Conclusion
The diagnosis of shock is uncommon at admission and
use of fluid bolus is rare. Fluid bolus is mostly used in chil-
dren with hypovolemic shock secondary to dehydration
and clinicians mostly prescribe the fluid and amounts
recommended in current guidance. Further improvements
can be made in identifying and treating children with
shock, perhaps particularly to improve availability of sim-
ple bedside monitoring devices.
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